On-demand HIV prevention pills worked well, study shows
Kaiser Permanente Northern California researchers say new as-needed PrEP regimen may increase use of the highly effective medication.
Ending the injustice
Imelda Dacones, MD, president and CEO of Northwest Permanente, focuses on health disparities and the role of physicians and all of health care to curb injustice.
Large drop in hospitalized heart attack patients seen during COVID-19 pandemic
Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus.
Advancing treatments through clinical trials
Kaiser Permanente’s clinical trials help advance treatment for health conditions and diseases ranging from heart disease and cancer to AIDS and COVID-19.
Building coronavirus testing capacity
As parts of the country slowly reopen, attention turns to effective population testing to monitor flare-ups.
Telehealth’s time
More Kaiser Permanente members get comfortable with virtual visits such as phone and video appointments during the COVID-19 pandemic.
TPMG physician designs DIY face shield
Pediatrician Kerstin Rosen, MD, of The Permanente Medical Group, designed a face shield for health care workers and enlisted the help of the 3D printing community.
Kaiser Permanente research centers prioritize urgent COVID-19 research projects, clinical trials
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
From the front lines: Fueling the fight against COVID-19 with hope and happiness
Dennis Truong, MD, assistant medical director of Telemedicine at the Mid-Atlantic Permanente Medical Group, shares moments of inspiration during the challenging days of coronavirus.
New Kaiser Permanente study provides information on coronavirus planning for health systems
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.